Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, $0.00001 par value
-
Shares outstanding
-
55,348,918
-
Total 13F shares
-
69,771,331
-
Share change
-
+9,434,456
-
Total reported value
-
$5,266,434,045
-
Put/Call ratio
-
43%
-
Price per share
-
$75.48
-
Number of holders
-
206
-
Value change
-
+$762,010,008
-
Number of buys
-
130
-
Number of sells
-
62
Institutional Holders of Apogee Therapeutics, Inc. - Common Stock, $0.00001 par value (APGE) as of Q4 2025
As of 31 Dec 2025,
Apogee Therapeutics, Inc. - Common Stock, $0.00001 par value (APGE) was held by
206 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
69,771,331 shares.
The largest 10 holders included
VR ADVISER, LLC, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., VANGUARD GROUP INC, T. Rowe Price Investment Management, Inc., RTW INVESTMENTS, LP, PERCEPTIVE ADVISORS LLC, Driehaus Capital Management LLC, and JANUS HENDERSON GROUP PLC.
This page lists
206
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.